Drug Pricing Check-Up: A Debrief of the FTC and DOJ's Third and Final Listening Session on Lowering Americans' Drug Prices Through Competition
August 7, 2025
On August 4, 2025, the U.S. Department of Commerce joined the U.S. Department of Justice and the Federal Trade Commission in hosting the final listening session on drug pricing, as mandated by President Trump's executive order, titled "Lowering Drug Prices by Once Again Putting Americans First." The session, "Turning Insights into Action to Reduce Drug Prices," brought together congressional staffers representing their members, who discussed the issues affecting drug pricing and proposed possible solutions.
Download PDF